Detailed Information on Publication Record
2010
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma
LUDWIG, Heinz, Zdeněk ADAM, Elena TOTHOVÁ, Roman HÁJEK, Boris LABAR et. al.Basic information
Original name
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma
Authors
LUDWIG, Heinz (40 Austria), Zdeněk ADAM (203 Czech Republic), Elena TOTHOVÁ (703 Slovakia), Roman HÁJEK (203 Czech Republic, guarantor), Boris LABAR (191 Croatia), Miklós EGYWD (348 Hungary), Ivan ŠPIČKA (203 Czech Republic), Heinz GISSLINGER (40 Austria), Johannes DRACH (40 Austria), Ingrid KUHN (40 Austria), Axel HINKE (276 Germany) and Niklas ZOJER (40 Austria)
Edition
Haematologica, Italy, Ferrata Storti Foundation, 2010, 0390-6078
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Italy
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 6.532
RIV identification code
RIV/00216224:14110/10:00045450
Organization unit
Faculty of Medicine
UT WoS
000281933200018
Keywords in English
thalidomide; multiple myeloma; thalidomide-interferon; progression free survival
Změněno: 25/11/2010 15:51, Mgr. Anna Potáčová, Ph.D.
Abstract
V originále
Thalidomide maintenance therapy after stem cell transplantation resulted in increased progression-free survival and overall survival in a few trials, but its role in non-transplant eligible patients with multiple myeloma remains unclear. This study assessed the impact of thalidomide-interferon in comparison to interferon maintenance therapy in elderly patients with multiple myeloma.
Links
LC06027, research and development project |
| ||
MSM0021622434, plan (intention) |
|